Scarica l'app Stockscreener
4.14
1.97%
0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.06
Aprire:
$4.03
Volume 24 ore:
845.89K
Relative Volume:
0.67
Capitalizzazione di mercato:
$255.69M
Reddito:
-
Utile/perdita netta:
$-117.81M
Rapporto P/E:
-2.2021
EPS:
-1.88
Flusso di cassa netto:
$74.30M
1 W Prestazione:
+11.74%
1M Prestazione:
+13.42%
6M Prestazione:
-52.52%
1 anno Prestazione:
+0.49%
Intervallo 1D:
$3.89
$4.19
Intervallo di 1 settimana:
$3.605
$4.19
Portata 52W:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Nome
Omeros Corporation
Settore
Industria
Telefono
206-676-5000
Indirizzo
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Confronta OMER con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
4.14 | 272.53M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-10 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-23 | Iniziato | D. Boral Capital | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2022-12-08 | Downgrade | UBS | Buy → Neutral |
| 2022-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Downgrade | Maxim Group | Buy → Hold |
| 2021-10-01 | Downgrade | Wedbush | Neutral → Underperform |
| 2021-09-27 | Iniziato | JP Morgan | Neutral |
| 2021-02-01 | Iniziato | UBS | Buy |
| 2020-10-20 | Iniziato | BofA Securities | Buy |
| 2020-08-21 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-14 | Reiterato | Maxim Group | Buy |
| 2019-05-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Iniziato | Seaport Global Securities | Buy |
| 2018-03-23 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-03-05 | Downgrade | Needham | Buy → Hold |
| 2017-11-08 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Reiterato | Maxim Group | Buy |
| 2017-03-17 | Reiterato | Needham | Buy |
| 2016-11-16 | Reiterato | Wedbush | Outperform |
| 2016-11-10 | Reiterato | Needham | Buy |
| 2016-08-10 | Reiterato | Maxim Group | Buy |
| 2016-06-03 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-02 | Reiterato | Needham | Buy |
| 2016-02-29 | Reiterato | Wedbush | Outperform |
| 2015-11-11 | Reiterato | Needham | Buy |
| 2015-08-18 | Reiterato | WBB Securities | Strong Buy |
| 2015-08-10 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Omeros Corporation Borsa (OMER) Ultime notizie
Omeros Corporation’s Price Action Aligns with Quant SignalsRisk Managed Intraday Trade Alerts Increase in Volume - 선데이타임즈
A&O Shearman advises D. Boral Capital LLC on USD22 million registered direct offering of Omeros Corporation - A&O Shearman
Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025 - The Joplin Globe
Omeros Announces Q2 2025 Earnings Release and Conference Call Details for August 14 - Stock Titan
Omeros Corporation stock daily chart insightsGrowth Summary Based on Market Positioning - Newser
Will earnings trigger a reversal in Omeros CorporationPrice Forecast Based on AI Analysis - Newser
What indicators show strength in Omeros CorporationPortfolio Booster Strategy with Trend Confidence - Newser
Published on: 2025-08-10 20:10:39 - Newser
Does Omeros Corporation fit your quant trading modelBuy Candidate Summary Based on Fundamentals - Newser
Volatility clustering patterns for Omeros CorporationFree Exit Ready Momentum Stock Watchlist - Newser
How institutional ownership impacts Omeros Corporation stockLong-Term Trend Tracking and Signal Summary - Newser
Omeros Corporation shares rise 1.32% premarket after positive investor sentiment in Europe. - AInvest
Seattle biopharma raises $22 million through stock sale - The Business Journals
Omeros announces pricing of $22 million registered direct offering - MSN
Omeros Corporation Stock Analysis and ForecastGet daily expert analysis for smarter investing - Jammu Links News
What is the dividend policy of Omeros Corporation stockConsistent triple returns - Jammu Links News
Omeros rises after pricing ~$22M stock offering - MSN
What institutional investors are buying Omeros Corporation stockMassive wealth growth - Jammu Links News
How strong is Omeros Corporation company’s balance sheetExceptional trading performance - Jammu Links News
What catalysts could drive Omeros Corporation stock higher in 2025Discover stocks with explosive upside potential - Jammu Links News
Why is Omeros Corporation stock attracting strong analyst attentionFree Stock Movement Tracking - Jammu Links News
How many analysts rate Omeros Corporation as a “Buy”Proven strategies for superior portfolio growth - Jammu Links News
How volatile is Omeros Corporation stock compared to the marketFree Trading Strategy Suggestions - Jammu Links News
When is Omeros Corporation stock expected to show significant growthPhenomenal investment performance - Jammu Links News
Is Omeros Corporation a good long term investmentAchieve rapid portfolio growth with smart picks - Jammu Links News
What is Omeros Corporation company’s growth strategyGet daily updates on promising stocks - Jammu Links News
Narsoplimab Study Insights Could Boost Omeros (OMER) Amid Eculizumab Concerns - AInvest
Is Omeros Corporation a growth stock or a value stockInvest smarter with comprehensive market analysis - Jammu Links News
What makes Omeros Corporation stock price move sharplyUnlock the power of real-time market data - jammulinksnews.com
What are Omeros Corporation company’s key revenue driversBuild a portfolio that withstands market volatility - Jammu Links News
Why Omeros Corporation stock attracts strong analyst attentionFree Real Time Trade Opportunity Alerts - Newser
Omeros Corporation Recovery Potential Based on Technical ToolsBreakout Momentum Picks With Protection Outlined - metal.it
Best data tools to analyze Omeros Corporation stockFree Daily Profit Focused Stock Screener - Newser
New Product Launches: Will They Boost Omeros Corporation Stock in 2025Free Consistent Profit Pattern Recognition Tools - Newser
Signal strength of Omeros Corporation stock in tech scanners3-Day Market Movement Forecast Analysis - Newser
How does Omeros Corporation generate profit in a changing economyChart Pattern Insights Backed By Experts - Jammu Links News
D. Boral Capital Acted as Exclusive Placement Agent to Omeros Corporation (Nasdaq: OMER) in Connection with its $22,000,000 Registered Direct Offering - ACCESS Newswire
Bank of New York Mellon Corp Increases Stock Holdings in Omeros Corporation (NASDAQ:OMER) - Defense World
Trend analysis for Omeros Corporation this weekReliable Setup Screener with Low Risk - Newser
Moving Average Trends for Omeros Corporation Stock: What They IndicateTechnical Stock Breakout Predictions Signal Entry Points - metal.it
How Omeros Corporation stock performs during market volatilityPrice Movement and Market Sentiment Analysis - Newser
Visual analytics tools that track Omeros Corporation performanceExit Strategy Guide With Risk Control Plan - Newser
Backtesting results for Omeros Corporation trading strategiesFree Safe Entry Stock Watch Suggestions - Newser
Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost - MSN
Omeros Shares Rise After $22 Million Direct Offering Prices - 富途牛牛
Is Omeros Corporation a Top Dividend Stock to Watch in 2025Free Proven Entry Plan With Low Risk Trade - Newser
These Numbers Prove Just How Vibrant The Omeros Corporation (NASDAQ: OMER) Stock Has Been - Stocksregister
Is it the right time to buy Omeros Corporation stockUnlock powerful stock screening techniques - Jammu Links News
Real time scanner hits for Omeros Corporation explainedMomentum Stocks with Breakout Potential - Newser
Omeros Corporation Azioni (OMER) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.02%
3.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):